Showing 1 to 1 of 1 results
english.elpais.com
🌐 85% Global Worthiness


New Drug Shows Promise in Treating Lung Cancer in Non-Smokers
A clinical trial of the drug zongertinib shows promise in treating HER2-mutated lung cancer in non-smokers, with 70% of participants experiencing tumor shrinkage; this offers hope for a previously difficult-to-treat cancer subtype that affects approximately 6,000 non-smokers annually in Spain.
New Drug Shows Promise in Treating Lung Cancer in Non-Smokers
A clinical trial of the drug zongertinib shows promise in treating HER2-mutated lung cancer in non-smokers, with 70% of participants experiencing tumor shrinkage; this offers hope for a previously difficult-to-treat cancer subtype that affects approximately 6,000 non-smokers annually in Spain.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results